Literature DB >> 9665979

Dengue and dengue hemorrhagic fever.

D J Gubler1.   

Abstract

Dengue fever, a very old disease, has reemerged in the past 20 years with an expanded geographic distribution of both the viruses and the mosquito vectors, increased epidemic activity, the development of hyperendemicity (the cocirculation of multiple serotypes), and the emergence of dengue hemorrhagic fever in new geographic regions. In 1998 this mosquito-borne disease is the most important tropical infectious disease after malaria, with an estimated 100 million cases of dengue fever, 500,000 cases of dengue hemorrhagic fever, and 25,000 deaths annually. The reasons for this resurgence and emergence of dengue hemorrhagic fever in the waning years of the 20th century are complex and not fully understood, but demographic, societal, and public health infrastructure changes in the past 30 years have contributed greatly. This paper reviews the changing epidemiology of dengue and dengue hemorrhagic fever by geographic region, the natural history and transmission cycles, clinical diagnosis of both dengue fever and dengue hemorrhagic fever, serologic and virologic laboratory diagnoses, pathogenesis, surveillance, prevention, and control. A major challenge for public health officials in all tropical areas of the world is to develop and implement sustainable prevention and control programs that will reverse the trend of emergent dengue hemorrhagic fever.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665979      PMCID: PMC88892          DOI: 10.1128/CMR.11.3.480

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  118 in total

1.  STANDARDIZED DIAGNOSTIC COMPLEMENT FIXATION METHOD AND ADAPTATION TO MICRO TEST. I. LABORATORY BRANCH COMPLEMENT FIXATION METHOD BY LABORATORY BRANCH TASK FORCE. II. ADAPTATION OF LBCF METHOD TO MICRO TECHNIQUE.

Authors:  H L CASEY
Journal:  Public Health Monogr       Date:  1965

2.  A program for prevention and control of epidemic dengue and dengue hemorrhagic fever in Puerto Rico and the U.S. Virgin Islands.

Authors:  D J Gubler; A Casta-Valez
Journal:  Bull Pan Am Health Organ       Date:  1991

Review 3.  The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future.

Authors:  D J Gubler
Journal:  Ann Acad Med Singapore       Date:  1998-03       Impact factor: 2.473

4.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

5.  Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus.

Authors:  C J Lai; B T Zhao; H Hori; M Bray
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

6.  A case of natural concurrent human infection with two dengue viruses.

Authors:  D J Gubler; G Kuno; G E Sather; S H Waterman
Journal:  Am J Trop Med Hyg       Date:  1985-01       Impact factor: 2.345

7.  Antibody-enhanced dengue virus infection in primate leukocytes.

Authors:  S B Halstead; E J O'Rourke
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

8.  Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga.

Authors:  D J Gubler; D Reed; L Rosen; J R Hitchcock
Journal:  Am J Trop Med Hyg       Date:  1978-05       Impact factor: 2.345

Review 9.  Hemostatic defects in dengue hemorrhagic fever.

Authors:  N Bhamarapravati
Journal:  Rev Infect Dis       Date:  1989 May-Jun

10.  Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay.

Authors:  E A Henchal; J M McCown; M C Seguin; M K Gentry; W E Brandt
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

View more
  834 in total

1.  Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys.

Authors:  N M Ferguson; C A Donnelly; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

2.  Evaluation of four methods for detection of immunoglobulin M antibodies to dengue virus.

Authors:  S L Branch; P N Levett
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

3.  Widespread intra-serotype recombination in natural populations of dengue virus.

Authors:  M Worobey; A Rambaut; E C Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 4.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Etiology of interepidemic periods of mosquito-borne disease.

Authors:  S I Hay; M F Myers; D S Burke; D W Vaughn; T Endy; N Ananda; G D Shanks; R W Snow; D J Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus.

Authors:  J D Callahan; S J Wu; A Dion-Schultz; B E Mangold; L F Peruski; D M Watts; K R Porter; G R Murphy; W Suharyono; C C King; C G Hayes; J J Temenak
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

7.  Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies.

Authors:  Wei-Kung Wang; Su-Ru Lin; Chao-Min Lee; Chwan-Chuen King; Shan-Chwen Chang
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Quantitative competitive reverse transcription-PCR for quantification of dengue virus RNA.

Authors:  W K Wang; C N Lee; C L Kao; Y L Lin; C C King
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

9.  Serotype-cross-reactive immunoglobulin M responses in dengue virus infections determined by enzyme-linked immunosorbent assay.

Authors:  M Nawa; K I Yamada; T Takasaki; T Akatsuka; I Kurane
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

10.  Genetic manipulation of vectors: A potential novel approach for control of vector-borne diseases.

Authors:  B J Beaty
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.